Company profile
NGI
Omics for Indonesia 133111i
- Industry
- Biotechnology Research
- Employees
- 45
- Headquarters
- Cilandak Barat, Jakarta
- Founded
- 2022
- LinkedIn followers
- 2,283
- Office locations
- 1
NGI company summary
NGI is a company in the Biotechnology Research industry, headquartered in Cilandak Barat, Jakarta, founded in 2022. On LinkedIn the company has around 45 employees and 2,283 followers. Its listed specialties include Biotechnology, Next Generation Sequencing, Laboratory, Health Clinic, Research.
What technology does NGI use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NGI
Naleya Genomik Indonesia (NGI) is a biotechnology company driving the future of precision health in Indonesia. As one of the country’s leading genomics laboratories, we provide high-quality, affordable, and clinically actionable genetic testing in reproductive health, rare diseases, and inherited conditions - powered by advanced infrastructure and international technology transfer. We collaborate with hospitals, government institutions, and academic partners to localize cutting-edge biotechnology, accelerate clinical adoption, and support Indonesia’s national healthcare transformation. NGI is building a robust, scalable, and trusted genomics ecosystem - from clinic to community - with a mission to make precision healthcare accessible, sustainable, and impactful for all Indonesians. From Indonesia. By Indonesia. For Indonesia.
Specialties
Where is NGI located?
NGI lists 1 location.
Compare companies similar to NGI
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NGI naleya-genomics.com | Biotechnology Research | 45 | 2022 | Cilandak Barat, Jakarta |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NGI
What does NGI do?
Naleya Genomik Indonesia (NGI) is a biotechnology company driving the future of precision health in Indonesia. As one of the country’s leading genomics laboratories, we provide high-quality, affordable, and clinically actionable genetic testing in reproductive health, rare diseases, and inherited conditions - powered by advanced infrastructure and international technology transfer. We collaborate with hospitals, government institutions, and academic partners to localize cutting-edge biotechnology, accelerate clinical adoption, and support Indonesia’s national healthcare transformation. NGI is building a robust, scalable, and trusted genomics ecosystem - from clinic to community - with a mission to make precision healthcare accessible, sustainable, and impactful for all Indonesians. From Indonesia. By Indonesia. For Indonesia.
How many employees does NGI have?
NGI has around 45 employees on LinkedIn.
Where is NGI headquartered?
NGI is headquartered in Cilandak Barat, Jakarta.
When was NGI founded?
NGI was founded in 2022.
Build a lead list from companies like NGI
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.